JPRN-UMIN000018996已完成未知
Study of the safety of SGLT-2 inhibitors for heart failure patients with type 2 diabetes mellitus - SGLT-2 inhibitors for volume overload of heart failure patients with diabetes mellitus
ippon Medical School Department of Cardiovascular Medicine0 个研究点目标入组 20 人开始时间: 2015年9月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Type 1 diabetes 2) With severe renal dysfunction (eGRF <30 mL/min or patient undergoing artificial dialysis) 3) Heart failure patient whose NYHA functional classification is IV 4) SGLT-2 inhibitor has been administered from admission to registration 5) Physicians and other staff have been deemed inappropriate for registration of this study
研究者
相似试验
招募中
不适用
Efficacy and safety of SGLT2 inhibitor in patients with diabetic kidneyDiabetic nephropathyJPRN-UMIN000031454ihon University40
尚未招募
Unknown
Adverse drug reaction of SGLT2 inhibitorsCTRI/2024/05/067860A
已完成
Unknown
Efficacy of SGLT2 inhibitors in heart failure patients with preserved left ventricular functioHeart failureJPRN-UMIN000053988ihon University School of Medicine, Division of Cardiology, Department of Medicine35
尚未招募
不适用
The impact of the SGLT2 inhibitor on cardiovascular risk factors in patients with type 2 diabetes, an explanatory randomized trialType 2 diabetesJPRN-UMIN000021669Tokyo Medical University60
招募中
不适用
Efficacy and Safety of SGLT2 inhibitors in patients with type 1 diabete.type 1 diabetesJPRN-UMIN000044317Hokkaido University Hospital200